Journal of Diabetes Research

Journal of Diabetes Research / 2012 / Article
Special Issue

Glucagon-Like Peptide-1 and Diabetes 2012

View this Special Issue

Editorial | Open Access

Volume 2012 |Article ID 768760 | https://doi.org/10.1155/2012/768760

Matteo Monami, Giovanni Di Pasquale, Anna Rowzee, Carlo Maria Rotella, Edoardo Mannucci, "Glucagon-Like Peptide-1 and Diabetes 2012", Journal of Diabetes Research, vol. 2012, Article ID 768760, 1 page, 2012. https://doi.org/10.1155/2012/768760

Glucagon-Like Peptide-1 and Diabetes 2012

Received21 Nov 2012
Accepted21 Nov 2012
Published31 Dec 2012

The present special issue was aimed at elucidating the role and the effects of glucagon-like peptide-1 (GLP-1) in type 2 diabetes. GLP-1 is a gastrointestinal hormone, mainly secreted after meals, capable of increasing glucose-stimulated insulin release and inhibits food intake. The physiological activity of this hormone has been demonstrated to be impaired in obese subjects and in patients with type 2 diabetes in comparison with healthy subjects.

Available data suggest that GLP-1 plays a relevant role in the regulation of postprandial glucose metabolism in physiologic conditions. Several new drugs act through the GLP-1 signaling system to stimulate insulin release and regulate blood glucose levels in patients with diabetes. Therefore, a special issue exploring the physiological properties of GLP-1 and the possible applications in several clinical settings is particularly warranted.

This special issue is composed of 5 articles: two mechanistic studies and three systematic reviews and meta-analyses, exploring GLP-1-induced signaling mechanisms and molecular identification and cloning of the GLP-1 receptor. The reviews and meta-analyses are focused on the promising beneficial extraglycaemic effects of the incretin-based therapy, including those on lipid profile and cardiovascular risk.

Matteo Monami
Giovanni Di Pasquale
Anna Rowzee
Carlo Maria Rotella
Edoardo Mannucci

Copyright © 2012 Matteo Monami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1092 Views | 915 Downloads | 3 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.